DE602005023138D1 - Anti-cea scfv-beta-lactamase konstrukte (cab moleküle) in adept - Google Patents

Anti-cea scfv-beta-lactamase konstrukte (cab moleküle) in adept

Info

Publication number
DE602005023138D1
DE602005023138D1 DE602005023138T DE602005023138T DE602005023138D1 DE 602005023138 D1 DE602005023138 D1 DE 602005023138D1 DE 602005023138 T DE602005023138 T DE 602005023138T DE 602005023138 T DE602005023138 T DE 602005023138T DE 602005023138 D1 DE602005023138 D1 DE 602005023138D1
Authority
DE
Germany
Prior art keywords
adept
lactamate
constructs
beta
cea scfv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005023138T
Other languages
English (en)
Inventor
Judith A Fox
Fiona A Harding
Harunur M Rashid
Volker Schellenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco US Inc
Original Assignee
Genencor International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor International Inc filed Critical Genencor International Inc
Publication of DE602005023138D1 publication Critical patent/DE602005023138D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE602005023138T 2004-04-15 2005-04-12 Anti-cea scfv-beta-lactamase konstrukte (cab moleküle) in adept Active DE602005023138D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56238604P 2004-04-15 2004-04-15
US63600204P 2004-12-14 2004-12-14
PCT/US2005/012270 WO2005111078A2 (en) 2004-04-15 2005-04-12 Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept

Publications (1)

Publication Number Publication Date
DE602005023138D1 true DE602005023138D1 (de) 2010-10-07

Family

ID=35394728

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005023138T Active DE602005023138D1 (de) 2004-04-15 2005-04-12 Anti-cea scfv-beta-lactamase konstrukte (cab moleküle) in adept

Country Status (7)

Country Link
US (2) US8088609B2 (de)
EP (1) EP1735350B1 (de)
JP (1) JP4699450B2 (de)
AT (1) ATE478894T1 (de)
CA (1) CA2562711C (de)
DE (1) DE602005023138D1 (de)
WO (1) WO2005111078A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10370680B2 (en) 2014-02-24 2019-08-06 Sangamo Therapeutics, Inc. Method of treating factor IX deficiency using nuclease-mediated targeted integration
CN107164412B (zh) * 2017-06-30 2020-10-23 山东兴瑞生物科技有限公司 一种安全型抗cea嵌合抗原受体修饰t细胞的制备方法及其应用
EP4148065A1 (de) * 2020-05-08 2023-03-15 SMT Bio Co., Ltd. Chimärer antigenrezeptor zur behandlung von krebs

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4522611A (en) * 1982-12-27 1985-06-11 Esco Corporation Sprocket assembly with replaceable teeth
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US4711845A (en) 1984-08-31 1987-12-08 Cetus Corporation Portable temperature-sensitive control cassette
EP0196864A3 (de) 1985-03-25 1988-03-23 Cetus Corporation Behandlung und Sekretion von rekombinanten Proteinen mittels alkalischer Phosphatase, dazu verwendbare DNA-Sequenzen und mittels dieser Sequenzen transformierte Zellen
NZ225599A (en) * 1987-08-04 1991-09-25 Bristol Myers Co Antibody-enzyme conjugates and combinations with prodrugs for the treatment of tumour cells
US5773435A (en) 1987-08-04 1998-06-30 Bristol-Myers Squibb Company Prodrugs for β-lactamase and uses thereof
US4975278A (en) 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
US5766883A (en) 1989-04-29 1998-06-16 Delta Biotechnology Limited Polypeptides
US5081235A (en) 1989-07-26 1992-01-14 City Of Hope Chimeric anti-cea antibody
US5843440A (en) 1990-10-03 1998-12-01 Redcell Canada, Inc. Cellular and serum protein anchors for modulating pharmacokinetics
AU649275B2 (en) * 1990-11-06 1994-05-19 Bristol-Myers Squibb Company Prodrugs for beta-lactamase and uses thereof
PT730470E (pt) 1993-11-10 2002-08-30 Enzon Inc Conjugados melhorados de interferao-polimero
CA2250579A1 (en) * 1996-05-04 1997-11-13 Zeneca Limited Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
US6835550B1 (en) 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
TWI310684B (en) 2000-03-27 2009-06-11 Bristol Myers Squibb Co Synergistic pharmaceutical kits for treating cancer
US20030068792A1 (en) 2000-12-14 2003-04-10 Yiyou Chen Targeted enzymes
US20030147874A1 (en) 2000-12-14 2003-08-07 Volker Schellenberger Targeted enzyme prodrug therapy
WO2002048372A2 (en) 2000-12-14 2002-06-20 Genencor International, Inc. Target enzymes
JP4688343B2 (ja) * 2001-05-16 2011-05-25 ルネサスエレクトロニクス株式会社 強誘電体メモリ装置
US20030100467A1 (en) 2001-09-12 2003-05-29 Wolfgang Aehle Binding phenol oxidizing enzyme-peptide complexes
EP1461085A2 (de) * 2002-01-03 2004-09-29 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Immunokonjugate zur behandlung von tumoren
AU2003256266A1 (en) 2002-06-12 2003-12-31 Genencor International, Inc. Methods and compositions for milieu-dependent binding of a targeted agent to a target
US20110160440A1 (en) * 2003-12-12 2011-06-30 Genencor International, Inc. Cab Molecules

Also Published As

Publication number Publication date
EP1735350A2 (de) 2006-12-27
US8088609B2 (en) 2012-01-03
CA2562711C (en) 2013-09-17
WO2005111078A9 (en) 2006-03-30
CA2562711A1 (en) 2005-11-24
JP2008501313A (ja) 2008-01-24
EP1735350B1 (de) 2010-08-25
JP4699450B2 (ja) 2011-06-08
WO2005111078A3 (en) 2006-07-27
US20080096810A1 (en) 2008-04-24
US8728470B2 (en) 2014-05-20
ATE478894T1 (de) 2010-09-15
US20120107314A1 (en) 2012-05-03
WO2005111078A2 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
IL273422A (en) Methods and systems for extracorporeal organ treatment
LTPA2017011I1 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
CY1119102T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεισαυτων
MX2007005202A (es) Polisacaridos de estreptococo modificados y usos de los mismos.
CA115720S (en) Lid
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
EP2244735A4 (de) Antikörpertherapie zur verwendung im verdauungstrakt
WO2008150530A3 (en) Cripto binding molecules
TW200641091A (en) Organometallic complexes
TR201909522T4 (tr) Anti-tümör aktivitesine sahip bir nonapeptit.
ATE535552T1 (de) Phenantrolinhaltige komplexe
ATE478894T1 (de) Anti-cea scfv-beta-lactamase konstrukte (cab moleküle) in adept
WO2006116076A3 (en) Tab molecules
AU303295S (en) Belt
AU306244S (en) Lotion applicator
TR200302193T4 (tr) Kombinasyon kemoterapisi.
CA114867S (en) Apparatus for optical authentication of documents
ATE307838T1 (de) Klebstoffzubereitungen
CA118573S (en) Notebook
CA112676S (en) Notebook
CA113897S (en) Traction chain
HN2002000177A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso.
AU302354S (en) Pump
AU304010S (en) 3-head dry shaver
CA119473S (en) All-terrain vehicle

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DANISCO US INC., PALO ALTO, CALIF., US